Sen Li

150 Ha Ping Road
Harbin, 150081, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.

Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.

Journal: Technology in cancer research & treatment

Published: February 15, 2019

Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells.

Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 21, 2018

Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.

Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.

Journal: Cancer management and research

Published: December 26, 2017

Clinicopathological features and prognoses in younger and older patients with gastric cancer.

Clinicopathological features and prognoses in younger and older patients with gastric cancer.

Journal: OncoTargets and therapy

Published: October 17, 2017

Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy.

Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy.

Journal: OncoTargets and therapy

Published: September 02, 2017

Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer.

Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer.

Journal: OncoTargets and therapy

Published: July 15, 2017

Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.

Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.

Journal: Journal of cancer research and clinical oncology

Published: June 23, 2017

Addition of peritonectomy to gastrectomy can predict good prognosis of gastric adenocarcinoma patients with intraoperatively proven single P1/P2 carcinomatosis.

Addition of peritonectomy to gastrectomy can predict good prognosis of gastric adenocarcinoma patients with intraoperatively proven single P1/P2 carcinomatosis.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: June 17, 2017

Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.

Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.

Journal: OncoTargets and therapy

Published: May 30, 2017

Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.

Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: May 02, 2017

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis.

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis.

Journal: OncoTargets and therapy

Published: March 01, 2017

Decreased Expression of Selenoproteins as a Poor Prognosticator of Gastric Cancer in Humans.

Decreased Expression of Selenoproteins as a Poor Prognosticator of Gastric Cancer in Humans.

Journal: Biological trace element research

Published: November 25, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026